Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.03 NZD Market Closed
Market Cap: 8.6m NZD
Have any thoughts about
Rua Bioscience Ltd?
Write Note

Rua Bioscience Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Rua Bioscience Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Rua Bioscience Ltd
NZX:RUA
Other Current Liabilities
NZ$75.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Other Current Liabilities
NZ$35k
CAGR 3-Years
27%
CAGR 5-Years
10%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Other Current Liabilities
NZ$5.4m
CAGR 3-Years
-4%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Other Current Liabilities
NZ$7.4k
CAGR 3-Years
N/A
CAGR 5-Years
-49%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Rua Bioscience Ltd
Glance View

Market Cap
8.6m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.001 NZD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Rua Bioscience Ltd's Other Current Liabilities?
Other Current Liabilities
75.2k NZD

Based on the financial report for Jun 30, 2024, Rua Bioscience Ltd's Other Current Liabilities amounts to 75.2k NZD.

What is Rua Bioscience Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
474%

Over the last year, the Other Current Liabilities growth was 474%.

Back to Top